Pinned post
Richard Scott
@Rich_Genomics
CEO @GenomicsEngland, Honorary Consultant and Associate Professor in Clinical Genetics @GreatOrmondSt. Still just about a runner
227 Following 1.5K Followers 228 Posts
Latest posts 5
So richly deserved @demishassabis, John Jumper and David Baker - an extraordinary leap, leveraging the (some itself Nobel prize winning) work of many over decades... to fastforward our understanding of biology and ability to innovate across so many applications to improve health
BREAKING NEWSView quoted post on X
The Royal Swedish Academy of Sciences has decided to award the 2024 #NobelPrize in Chemistry with one half to David Baker “for computational protein design” and the other half jointly to Demis Hassabis and John M. Jumper “for protein structure prediction.”
I’m thrilled the Generation Study has launched
Developing evidence on the potential of genomic newborn screening to be offered to all babies to enable earlier diagnosis and treatment for children with 200+ rare conditions
🧵...
tinyurl.com/NewbornStudy
Developing evidence on the potential of genomic newborn screening to be offered to all babies to enable earlier diagnosis and treatment for children with 200+ rare conditions
🧵...
tinyurl.com/NewbornStudy
The Generation Study is a ground-breaking research study in partnership with the NHS which will sequence the whole genomes of up to 100,000 newborn babies and look for 200+ rare conditions in early childhood.View quoted post on X
Find out more: ow.ly/RVuJ50TBVQf
@DHSCgovuk @NHSEngland
We’re delighted at @GenomicsEngland to be part of this work and supporting best practice in rare disease genomic testing. #teamgenomics
The @acgs_news position statement: Rare disease genomic testing in the UK and Ireland: promoting timely and equitable access, is online jmg.bmj.com/content/early/… Collaborative best practice guidance involving @Unique_charity @NHSgms @WalesGeneParkView quoted post on X
@GeneticAlliance @GenQA & others🧵
A wonderful couple of days hearing and talking about the impact genomics is already having and the even bigger change we believe it will bring if we develop the right evidence and infrastructure.
Totally captures what inspires our mission at @GenomicsEngland
Totally captures what inspires our mission at @GenomicsEngland
It's two weeks until the OHC Symposium! Session 2 RARE THERAPIES LAUNCH PAD features Dan O'Connor @ABPI_UK, @timyu @harvardmed, @Rich_Genomics @GenomicsEngland, and Dame June Raine @MHRAgovuk. The panel discussion will include Kath Bainbridge @DHSCgovuk and Mel Dixon @CureDhddsView quoted post on X